Raymond James Financial Services Advisors, Inc. Novavax Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 11,805 shares of NVAX stock, worth $95,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,805
Previous 10,674
10.6%
Holding current value
$95,148
Previous $135,000
10.37%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding NVAX
# of Institutions
292Shares Held
93.4MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$124 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$95.5 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$79.1 Million40.63% of portfolio
-
State Street Corp Boston, MA7.69MShares$62 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$47.9 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $630M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...